Physician profile
Jesse R Wolfe
NPI 1467802595
$89,033.02
in general payments reported to CMS, 2019-2025
40 companies · $4,832 in 2025
The $4,832 reported for 2025 was more than what 93% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,028 · 2020: $2,011 · 2021: $24K · 2022: $28K · 2023: $15K · 2024: $8,644 · 2025: $4,832.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Travel and Lodging: $8,887 · Food and Beverage: $4,398 · Royalty Or License: $213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,500.00 |
| Travel and Lodging | $8,887.21 |
| Food and Beverage | $4,397.77 |
| Royalty Or License | $212.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nvision Biomedical Technologies, INC. | $20,089.11 | 2021-2024 | Radian |
| Medshape, INC. | $14,984.31 | 2022-2025 | Dynanail Helix, Washer, 15 Mm, Lapidus Correction Jig, Right, Dynanail |
| Trilliant Surgical LLC. | $14,531.59 | 2022-2024 | Arsenal Sinus Support Plate, Arsenal Ankle 10 Hole 1/3 Tubular Plate |
| Dne LLC | $9,450.00 | 2021-2022 | |
| Elite Orthopedics, LLC | $6,262.82 | 2019-2025 | |
| Conetic Solutions, INC. | $3,794.29 | 2019-2021 | |
| Stryker Corporation | $3,288.71 | 2019-2024 | 7 X 23mm Citrelock Implant, Inbone, Allofiber |
| Arthrex, INC. | $3,051.00 | 2021 | |
| Encore Medical, LP | $2,726.11 | 2021-2022 | |
| Medline Industries LP | $2,244.24 | 2021-2023 | |
| Extremity Medical | $2,000.00 | 2025 | |
| Treace Medical Concepts, INC. | $1,473.67 | 2023-2025 | |
| Zimmer Biomet Holdings, INC. | $877.41 | 2023-2025 | Incore Lapidus, Stratum Foot Plating System, Tapestry |
| Vilex LLC | $865.97 | 2025 | Alphalok, Optix |
| Anika Therapeutics, INC. | $785.34 | 2021 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exactech, INC. | $639.82 | 2021 | |
| International Life Sciences | $170.13 | 2024 | Flexband |
| Triad Life Sciences INC. | $168.71 | 2022 | |
| Acumed LLC | $160.10 | 2025 | Acumed |
| Smith+Nephew, INC. | $150.97 | 2020-2021 | |
| Bone Support INC. | $144.38 | 2025 | Ceramentbone Void Filler, Cerament G |
| Restor3d, INC. | $132.75 | 2023 | |
| Spr Therapeutics, INC | $129.85 | 2024 | Sprint Pns System |
| Responsive Arthroscopy INC | $125.06 | 2023 | |
| Axogen | $107.19 | 2023 | Avance Nerve Graft |
| Convatec INC. | $105.97 | 2025 | |
| Trimed, INC. | $85.80 | 2022 | |
| Crossroads Extremity Systems, LLC | $71.35 | 2021 | |
| Biogennix, LLC | $66.88 | 2023 | Agilon |
| Depuy Synthes Sales INC. | $65.30 | 2024 | Monovisc, Orthovisc, Na |
| Henry Schein, INC. | $65.03 | 2023 | Welch-Allyn Medical Prod |
| Kerecis Limited | $52.17 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Organogenesis INC. | $51.28 | 2023 | Affinity |
| Solventum Corporation | $27.35 | 2024 | Prevena |
| Djo, LLC | $20.84 | 2025 | Cmf |
| Paragon 28, INC. | $16.46 | 2023 | Phantom Hindfoot |
| Averitas Pharma INC. | $13.48 | 2024 | Qutenza |
| Highridge Medical LLC | $13.16 | 2024 | Biomet Ebi Bone Healing System |
| Omeros Corporation | $12.83 | 2019 | |
| Kci USA, INC. | $11.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Wolfe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.